Insight Molecular Diagnostics Inc. Accounts Payable
Insight Molecular Diagnostics Inc. (IMDX) had Accounts Payable of $1.87 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $1.87M.
- 2026-03-31: Accounts Payable, Current $1.61M.
- 2025-12-31: Accounts Payable, Current $2.54M.
- 2025-09-30: Accounts Payable, Current $1.06M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.87M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.54M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.28M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $2.28M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.64M 10-K · filed 2026-03-26 | $2.28M 10-K · filed 2025-03-24 |
| 2024-09-30 | $872.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.05M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $908.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $953.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $875.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.25M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $1.83M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.46M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.58M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.81M 10-K · filed 2023-04-12 | $2.45M 10-K · filed 2022-03-11 |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.09M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $1.09M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $432.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $1.26M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.16M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $1.64M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $469.00K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $358.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $556.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $136.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $166.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $194.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $232.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $307.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $175.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $152.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $187.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $211.00K 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $422.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $870.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $192.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $403.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $285.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |